Literature DB >> 11270669

Incidence of blindness in southern Germany between 1990 and 1998.

C Trautner1, B Haastert, G Giani, M Berger.   

Abstract

AIMS/HYPOTHESIS: A reduction of diabetes-related blindness by at least one third was declared a primary objective for Europe in 1989 (St. Vincent Declaration). To ascertain a potential change of incidence rates, we collected data on blindness in a German district (population: about 5 million) over 9 years.
METHODS: We obtained complete lists of newly registered blindness-allowance recipients between 1990 and 1998 and population data on Württemberg-Hohenzollern, Germany. We estimated incidence rates of blindness in the general population and the diabetic population. To ascertain any time trend, we applied Poisson regression models.
RESULTS: There were 6371 newly registered blindness allowance recipients (1990-1998). Of these 67% were women and 27 % had diabetes. Mean age was 71.7 years. Standardised results in the diabetic population (incidence rates per 100,000 person-years; standard: diabetic population; 95 % CI): 1990: 72 (61;82); 1991: 88 (76;100); 1992: 77 (67;88); 1993: 82 (71;93); 1994: 62 (53;72); 1995: 82 (71;93); 1996: 70 (60;80); 1997: 69 (59;79); 1998: 59 (49;68). The Poisson model estimated a 3 % decrease of incident blindness in the diabetic population for each year (Relative risk per year 0.97; CI: 0.95; 0.99). No significant change could be observed in the non-diabetic population (Relative risk: 0.99; CI: 0.98; 1.00). Relative risks for each year varied between sub-groups according to sex, diabetic status and cause of blindness between 0.94 and 1.01. CONCLUSION/
INTERPRETATION: A slight reduction of incident blindness could be shown but a reduction by one third has not been reached. Several possible sources of bias in the data have to be considered.

Entities:  

Mesh:

Year:  2001        PMID: 11270669     DOI: 10.1007/s001250051592

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  7 in total

1.  The Prevalence of Visual Impairment in the Adult Population.

Authors:  Christian Wolfram; Alexander K Schuster; Heike M Elflein; Stefan Nickels; Andreas Schulz; Philipp S Wild; Manfred E Beutel; Maria Blettner; Thomas Münzel; Karl J Lackner; Norbert Pfeiffer
Journal:  Dtsch Arztebl Int       Date:  2019-04-26       Impact factor: 5.594

2.  Evidence for a considerable decrease in total and cause-specific incidences of blindness in Germany.

Authors:  Heiner Claessen; Jutta Genz; Bernd Bertram; Christoph Trautner; Guido Giani; Iris Zöllner; Andrea Icks
Journal:  Eur J Epidemiol       Date:  2012-06-19       Impact factor: 8.082

Review 3.  The changing epidemiology of diabetic microangiopathy in type 1 diabetes.

Authors:  P Rossing
Journal:  Diabetologia       Date:  2005-06-29       Impact factor: 10.122

4.  [Blindness in Germany: dimensions and perspectives].

Authors:  R P Finger
Journal:  Ophthalmologe       Date:  2007-10       Impact factor: 1.059

Review 5.  Type 2 diabetes: prevalence and relevance of genetic and acquired factors for its prediction.

Authors:  Wolfgang Rathmann; Christa Scheidt-Nave; Michael Roden; Christian Herder
Journal:  Dtsch Arztebl Int       Date:  2013-05-10       Impact factor: 5.594

6.  Prevalence and progression of visual impairment in patients newly diagnosed with clinical type 2 diabetes: a 6-year follow up study.

Authors:  Niels de Fine Olivarius; Volkert Siersma; Gitte Juul Almind; Niels Vesti Nielsen
Journal:  BMC Public Health       Date:  2011-02-04       Impact factor: 3.295

7.  The contribution of the English NHS Diabetic Eye Screening Programme to reductions in diabetes-related blindness, comparisons within Europe, and future challenges.

Authors:  Peter H Scanlon
Journal:  Acta Diabetol       Date:  2021-04-08       Impact factor: 4.280

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.